Oxford Nanopore Technologies (LON:ONT) Stock Rating Reaffirmed by Berenberg Bank

Oxford Nanopore Technologies (LON:ONT)‘s stock had its “buy” rating reaffirmed by Berenberg Bank in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They currently have a GBX 350 ($4.36) target price on the stock. Berenberg Bank’s price target indicates a potential upside of 270.37% from the stock’s current price.

Separately, Citigroup reiterated a “buy” rating and set a GBX 210 ($2.61) target price on shares of Oxford Nanopore Technologies in a report on Friday, April 12th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of GBX 303.75 ($3.78).

Oxford Nanopore Technologies Stock Performance

Shares of Oxford Nanopore Technologies stock opened at GBX 94.50 ($1.18) on Wednesday. The company has a market capitalization of £812.66 million, a PE ratio of -630.00 and a beta of 0.59. Oxford Nanopore Technologies has a 12 month low of GBX 92.20 ($1.15) and a 12 month high of GBX 279 ($3.47). The company has a current ratio of 5.01, a quick ratio of 6.01 and a debt-to-equity ratio of 6.47. The stock’s fifty day simple moving average is GBX 130.92 and its 200 day simple moving average is GBX 168.53.

Insiders Place Their Bets

In related news, insider Gurdial (Gordon) Sanghera acquired 39,196 shares of the firm’s stock in a transaction dated Wednesday, March 6th. The stock was bought at an average price of GBX 127 ($1.58) per share, for a total transaction of £49,778.92 ($61,968.03). In the last 90 days, insiders bought 39,421 shares of company stock worth $5,007,852. Corporate insiders own 30.07% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.